These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 21371901)

  • 1. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
    Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low-dose exogenous surfactant on infants with acute respiratory distress syndrome after cardiac surgery: a retrospective analysis.
    Zhang R; Wang X; Li S; Yan J
    BMC Pulm Med; 2020 Aug; 20(1):210. PubMed ID: 32762672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of the exogenous surfactant curosurf in combined therapy for acute respiratory failure in children after cardiosurgical interventions].
    Lobacheva GV; Khar'kin AV; Aksenov AV; Kvasnikov BB; Manerova AF; Bokeriia LA
    Anesteziol Reanimatol; 2005; (3):35-8. PubMed ID: 16076044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
    Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N
    Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective medicated (normal saline and exogenous surfactant) bronchoalveolar lavage in severe aspiration syndrome in children.
    Marraro GA; Luchetti M; Spada C; Galassini E; Giossi M; Piero AM
    Pediatr Crit Care Med; 2007 Sep; 8(5):476-81. PubMed ID: 17693914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome.
    Cogo PE; Facco M; Simonato M; Verlato G; Rondina C; Baritussio A; Toffolo GM; Carnielli VP
    Pediatrics; 2009 Nov; 124(5):e950-7. PubMed ID: 19822594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective and curative effects of prophylactic administration of pulmonary surfactant on neonatal respiratory distress syndrome].
    Chu GL; Wang J; Xin Y; Zheng J; Zheng RX; Bi DZ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):876-80. PubMed ID: 16759511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.
    Speer CP; Robertson B; Curstedt T; Halliday HL; Compagnone D; Gefeller O; Harms K; Herting E; McClure G; Reid M
    Pediatrics; 1992 Jan; 89(1):13-20. PubMed ID: 1727997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
    Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
    Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of surfactant administration in premature infants with severe respiratory distress syndrome].
    Morón A; Luaces J; Esteban JC; Medina D; Sánchez JM; Manzano JL
    Med Clin (Barc); 1996 Jun; 107(5):165-8. PubMed ID: 8758674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant therapy in infants and children: three years experience in a pediatric intensive care unit.
    Hermon MM; Golej J; Burda G; Boigner H; Stoll E; Vergesslich K; Strohmaier W; Pollak A; Trittenwein G
    Shock; 2002 Apr; 17(4):247-51. PubMed ID: 11954821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group.
    Verder H; Robertson B; Greisen G; Ebbesen F; Albertsen P; Lundstrøm K; Jacobsen T
    N Engl J Med; 1994 Oct; 331(16):1051-5. PubMed ID: 8090164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue.
    Bevilacqua G; Parmigiani S;
    J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First intention high-frequency oscillatory and conventional mechanical ventilation in premature infants without antenatal glucocorticoid prophylaxis.
    Salvo V; Zimmermann LJ; Gavilanes AW; Barberi I; Ricotti A; Abella R; Frigiola A; Giamberti A; Florio P; Tagliabue P; Tina LG; Nigro F; Temporini F; Gazzolo D
    Pediatr Crit Care Med; 2012 Jan; 13(1):72-9. PubMed ID: 21499177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial.
    Willson DF; Thomas NJ; Markovitz BP; Bauman LA; DiCarlo JV; Pon S; Jacobs BR; Jefferson LS; Conaway MR; Egan EA;
    JAMA; 2005 Jan; 293(4):470-6. PubMed ID: 15671432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surfactant treatment of newborn infants receiving continuous positive airway pressure treatment].
    Andersen T; Holm HS; Kamper J
    Ugeskr Laeger; 2006 Oct; 168(43):3723-7. PubMed ID: 17069738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surfactant-BL and inhaled nitric oxide in acute respiratory distress syndrome in cardiac surgical patients].
    Kozlov IA; Poptsov VN
    Anesteziol Reanimatol; 2005; (6):38-41. PubMed ID: 16499105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.